Kixta 125 mg is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications.
The common side effects that are likely to associate with Kixta 125 mg capsule are nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persist in you.
Inform your healthcare provider if you are allergic to Kixta 125 mg capsule and its ingredients. Before taking this medicine, it is vital to inform your doctor if you have any signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to some sugars. Consult your physician immediately if you experience symptoms such as dry cough, chest pain, or difficulty breathing, as it could indicate lung inflammation. Make sure you inform your physician of all the medicines, including supplements and herbal medicines; you are taking before you start treatment with this medication. Use effective birth control during the treatment and at least three weeks after the last dose. It is not recommended for adolescents and children under 18 years of age.
Uses of Kixta 125mg CapsuleTreatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer. Therapeutic Effects of Kixta 125mg Capsule
Kixta 125 mg capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading. Interaction of Kixta 125mg Capsule with other drugsInform your doctor about all medications, including prescribed, over-the-counter, nutritional, or vitamin supplements and herbal products that you take or have taken before the treatment. Concurrent use of Kixta 125 mg capsule with CYP3A4 inhibitors such as fentanyl has reported increased fentanyl toxicity. Certain medications may interact with the effectiveness of this drug.More Information about Kixta 125mg Capsule Keep Kixta 125 mg capsule out of sight and reach of children.Store at 20°C to 25°C.How to consume Kixta 125mg CapsuleTake Kixta 125 mg capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule. Safety Advices for Kixta 125mg Capsule
Pregnancy
It is not recommended to take Kixta 125 mg capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Breast Feeding
Taking a Kixta 125 mg capsule while breastfeeding is not recommended as it is not known whether it passes into the breast milk.
Lungs
It is not unknown whether Kixta 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Liver
Inform your physician if you have any liver disorders before taking Kixta 125 mg capsule, as it should be used with caution in liver disorder patients.
Alcohol
It is unknown whether it is safe to drink alcohol while taking Kixta 125 mg capsule. Check with your doctor for advice.
Driving
Kixta 125 mg capsule can cause tiredness. Avoid driving if you are unwell.
Side Effects of Kixta 125mg CapsuleSide effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious:
- Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
- Lung inflammation (chest pain, dry cough, or difficulty breathing)
Common:
- Tiredness
- Hair loss
- Dry skin, rash
- Infections
- Low blood cell counts
- Decreased of appetite
- Nausea, vomiting
- Diarrhea
- Swelling of lips and mouth
- Changes in taste
- Nose bleed
- Dry eye, blurred vision, increased tearing
Word of AdviceDuring Kixta 125 mg capsule treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment and for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether the capsule affects your blood cells.FAQs Q 1. Is Kixta 125 mg capsule targeted therapy?Yes, Kixta 125 mg capsule is a targeted therapy. This medication belongs to the class of cyclin-dependent kinase inhibitors.
Q 2. Do I lose hair on Kixta 125 mg capsule?Yes, Taking Kixta 125 mg capsule can cause hair loss or hair thinning. It is one of the side effects of this medication. Consult your doctor if any side effects disturb you.
Q 3. Can children use Kixta 125 mg capsule?No, Kixta 125 mg capsule is not recommended for adolescents and children under 18.
Q 4. Does Kixta 125 mg capsule affect fertility?Yes, Kixta 125 mg capsule may reduce fertility in men. It may affect your ability to become a father and a child. Hence, men should consider sperm preservation before taking this medication.
Q 5. Does Kixta 125 mg capsule affect blood cell count?Kixta 125 mg capsule might reduce the number of white blood cells and weaken the immune system. It could lead to an increase in the risk of infections. Regular blood tests while taking the capsule are advised.
Fact Box of Kixta 125mg CapsuleMolecule name: Palbociclib | Therapeutic class: Cyclin-dependent kinase inhibitor |
Pharmacological class: Anti-Neoplastics | Indications: HR-positive, HER2-negative advanced or metastatic breast cancer |
-700x700-product_popup.jpg "Kixta 125mg Capsule")
-700x700-product_popup.jpg "Kixta 125mg Capsule")
-700x700-product_popup.jpg "Kixta 125mg Capsule")
-700x700-product_thumb.jpg "Kixta 125mg Capsule")
